Transcutaneous Vagus Nerve Stimulation for Attention and Memory

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Traumatic Brain Injury (TBI) Patients
Interventions
OTHER

Transcutaneous vagus nerve stimulation for attention in veterans with TBI

taVNS does not require surgery or medication, offering a safe and accessible treatment option. Each participant undergoes both an active taVNS session and a sham (placebo) session. Sham stimulation mimics the sensory experience of taVNS but does not deliver electrical currents to the vagus nerve, ensuring blinding and providing robust comparisons. The study is completed in a single visit lasting 2.5 to 3 hours, minimizing participant burden.

DEVICE

Soterix Medical Vagus Nerve Stimulation mini-CT

Soterix Medical min-CT VNS device is used for non-invasive stimulation procedures and trials. It has blinding features such as single-blind for this study in which patients will either receive active or shame taVNS.

Trial Locations (2)

77030

NOT_YET_RECRUITING

Michael E. DeBakey VA Medical Center, Houston

RECRUITING

Michael E. DeBakey VA Medical Center, Houston

All Listed Sponsors
collaborator

Michael E. DeBakey VA Medical Center

FED

lead

Baylor College of Medicine

OTHER

NCT06723743 - Transcutaneous Vagus Nerve Stimulation for Attention and Memory | Biotech Hunter | Biotech Hunter